Fidasimtamab (Synonyms: IBI-315; BH2950) |
| Catalog No.GC69111 |
Fidasimtamab (IBI-315; BH2950) is a recombinant human IgG1 bispecific antibody that can simultaneously target, bind and inhibit HER2 and PD-1 and their downstream signaling pathways, connecting PD-1 expressing T cells with HER2-expressing tumor cells. Fidasimtamab has potential immune-suppressive and anti-tumor activity.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2377419-89-9
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for Fidasimtamab
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for Fidasimtamab
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *